Cannabis Medicine: A Comprehensive Clinical Guide – TheAnswerPage
This course bundle is comprised of 2 courses: “Cannabis and Cannabinoids in Clinical Practice” and “Cannabis Use Disorder and Cannabinoid Hyperemesis Syndrome.” Designed for today’s clinical environment, “Cannabis and Cannabinoids in Clinical Practice” bridges the gap between cannabis science and patient care. It provides a clear, evidence based foundation to help clinicians confidently counsel patients on cannabis use, evaluate therapeutic applications, and recognize risks. Key topics include how cannabinoids work in the body, cannabinoid pharmacology, clinical effects, risks and contraindications of cannabis use, and cannabis-related disorders. “Cannabis Use Disorder and Cannabinoid Hyperemesis Syndrome” covers presentation, diagnostic criteria, screening tools, cannabis withdrawal, treatment strategies, and management of recurrent nausea and vomiting. Key concepts are introduced and reinforced through clinically relevant case scenarios.
Cost: $239
View Offer chevron_rightKey Features
Subscribers can complete the curriculum and refer back to the content at any point throughout the 2-year accreditation period
Topics Covered
• Review the structure and function of the endocannabinoid system including its role in physiologic homeostasis
• Describe the major phytochemicals of the cannabis plant, including cannabinoids and terpenes, and their proposed biologic effects
• Compare the legal landscape of cannabis at the state level to the federal level
• Contrast the regulatory landscape of cannabis at the state level to the federal level
• Describe the pharmacokinetic profile of cannabinoids for several modes of administration, including inhalation, oral, sublingual, transdermal and rectal
• Identify clinically significant drug interactions that may occur between cannabinoid-based drugs and medications
• Discuss the acute and chronic cognitive and physiologic effects of cannabinoids
• Discuss the therapeutic use of cannabinoid-based drugs across a range of disease states
• Discuss the use of cannabinoid-based drugs in a variety of vulnerable populations
• Define cannabinoid hyperemesis syndrome, including its clinical features and general management principles
• Define cannabis use disorder, including its diagnostic features and general treatment approaches
• Describe the clinical presentation of cannabinoid hyperemesis syndrome
• Describe the management of cannabinoid hyperemesis syndrome
• List the diagnostic criteria for cannabis use disorder
• Describe the management of cannabis use disorder
• Describe the clinical features and diagnostic criteria of cannabis withdrawal
• Describe the use of the Cannabis Withdrawal Scale to assess withdrawal symptom severity
Target Audience
All healthcare providers including doctors, nurses, nurse practitioners, and pharmacists.
Additional credit info
Content provides Accreditation Council for Continuing Medical Education (ACCME – AMA PRA Category 1 Credits™), Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC)